{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:15602"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:15602","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Defining neuroinflammatory pathways in cryptococcal meningitis","abstract":"Cryptococcus neoformans is a fungus that is ubiquitous in the environment and can cause lethal meningitis in immunocompromised individuals, with deficits in T cell responses, such as HIV/AIDS, being particularly vulnerable. Cryptococcal meningitis (CM) causes approximately 100,000 deaths per year and those who do survive often suffer from long-term neurological disorders. Tissue-resident macrophage populations in the CNS are the first line of defence against invading pathogens. In this thesis, I have explored the early immune response in the brain when C. neoformans first invades, focusing on microglial responses and inflammation in the surrounding meninges. This work has shown that the immune response in the brain and meninges is generally delayed. In the brain, a unique population of microglia develops that hosts live C. neoformans and may contribute towards inflammation and interaction with lymphocytes. In the meninges, complement activation and macrophage-platelet interactions coincided with C. neoformans proliferation in this tissue. Taken together, this work demonstrates C. neoformans has evolved strategies to overcome innate immune responses at the brain borders and within the brain parenchyma. This has important implications for developing immune therapies to treat and prevent cryptococcal meningitis, as targeting adaptive immune defects may not be sufficient to prevent disease.","abstract_html":"Cryptococcus neoformans is a fungus that is ubiquitous in the environment and can cause lethal meningitis in immunocompromised individuals, with deficits in T cell responses, such as HIV/AIDS, being particularly vulnerable. Cryptococcal meningitis (CM) causes approximately 100,000 deaths per year and those who do survive often suffer from long-term neurological disorders. Tissue-resident macrophage populations in the CNS are the first line of defence against invading pathogens. In this thesis, I have explored the early immune response in the brain when C. neoformans first invades, focusing on microglial responses and inflammation in the surrounding meninges. This work has shown that the immune response in the brain and meninges is generally delayed. In the brain, a unique population of microglia develops that hosts live C. neoformans and may contribute towards inflammation and interaction with lymphocytes. In the meninges, complement activation and macrophage-platelet interactions coincided with C. neoformans proliferation in this tissue. Taken together, this work demonstrates C. neoformans has evolved strategies to overcome innate immune responses at the brain borders and within the brain parenchyma. This has important implications for developing immune therapies to treat and prevent cryptococcal meningitis, as targeting adaptive immune defects may not be sufficient to prevent disease.","abstract_has_math":false,"creators":["Hain Porter, Sofia Alicia"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-12","date_published":"2024-12","updated_at":"2026-11-19T09:32:59Z","subjects":["QP Physiology","QR Microbiology","QR180 Immunology","RB Pathology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.grantnumber","label":"Dc Identifier Grantnumber","values":["1000374"],"render_values":[{"text":"1000374","href":null,"code":true}]}],"person_identifier_entries":[{"key":"person:identifier.orcid","label":"ORCID","values":["0000000179932828"],"render_values":[{"text":"0000-0001-7993-2828","href":"https://orcid.org/0000-0001-7993-2828","code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/15602/1/HainPorter2024PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A15602","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["wellcome_trust"]},{"key":"dc:creator","label":"Author","values":["Hain Porter, Sofia Alicia"]},{"key":"person:identifier.orcid","label":"ORCID","values":["0000000179932828"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024-12-09"]},{"key":"dc:date.issued","label":"Date","values":["2024-12"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/15602/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QP Physiology","QR Microbiology","QR180 Immunology","RB Pathology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.grantnumber","label":"Dc Identifier Grantnumber","values":["1000374"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/15602/1/HainPorter2024PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Cryptococcus neoformans is a fungus that is ubiquitous in the environment and can cause lethal meningitis in immunocompromised individuals, with deficits in T cell responses, such as HIV/AIDS, being particularly vulnerable. Cryptococcal meningitis (CM) causes approximately 100,000 deaths per year and those who do survive often suffer from long-term neurological disorders. Tissue-resident macrophage populations in the CNS are the first line of defence against invading pathogens. In this thesis, I have explored the early immune response in the brain when C. neoformans first invades, focusing on microglial responses and inflammation in the surrounding meninges. This work has shown that the immune response in the brain and meninges is generally delayed. In the brain, a unique population of microglia develops that hosts live C. neoformans and may contribute towards inflammation and interaction with lymphocytes. In the meninges, complement activation and macrophage-platelet interactions coincided with C. neoformans proliferation in this tissue. Taken together, this work demonstrates C. neoformans has evolved strategies to overcome innate immune responses at the brain borders and within the brain parenchyma. This has important implications for developing immune therapies to treat and prevent cryptococcal meningitis, as targeting adaptive immune defects may not be sufficient to prevent disease."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Defining neuroinflammatory pathways in cryptococcal meningitis"]}]}],"canonical_facts":{"dc:contributor.sponsor":["wellcome_trust"],"dc:creator":["Hain Porter, Sofia Alicia"],"dc:date":["2024-12-09"],"dc:date.issued":["2024-12"],"dc:description.abstract":["Cryptococcus neoformans is a fungus that is ubiquitous in the environment and can cause lethal meningitis in immunocompromised individuals, with deficits in T cell responses, such as HIV/AIDS, being particularly vulnerable. Cryptococcal meningitis (CM) causes approximately 100,000 deaths per year and those who do survive often suffer from long-term neurological disorders. Tissue-resident macrophage populations in the CNS are the first line of defence against invading pathogens. In this thesis, I have explored the early immune response in the brain when C. neoformans first invades, focusing on microglial responses and inflammation in the surrounding meninges. This work has shown that the immune response in the brain and meninges is generally delayed. In the brain, a unique population of microglia develops that hosts live C. neoformans and may contribute towards inflammation and interaction with lymphocytes. In the meninges, complement activation and macrophage-platelet interactions coincided with C. neoformans proliferation in this tissue. Taken together, this work demonstrates C. neoformans has evolved strategies to overcome innate immune responses at the brain borders and within the brain parenchyma. This has important implications for developing immune therapies to treat and prevent cryptococcal meningitis, as targeting adaptive immune defects may not be sufficient to prevent disease."],"dc:format":["text"],"dc:identifier.grantnumber":["1000374"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/15602/1/HainPorter2024PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/15602/"],"dc:subject":["QP Physiology","QR Microbiology","QR180 Immunology","RB Pathology"],"dcterms:accessrights":["public"],"dc:title":["Defining neuroinflammatory pathways in cryptococcal meningitis"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"],"person:identifier.orcid":["0000000179932828"]},"updated_at":"2026-11-19T09:32:59Z"}